Conclusions:
Our data show for the first time a distinct gene expression profile characterizing IDH mutant tumors which display significant downregulation of inflammatory response pathways and immune-related genes, coupled with significantly lower B cell infiltration and higher endothelial abundance. • These findings contribute to further the understanding of IDH mutant BC and may inform the future development of rational combination therapies.